Forum Markets INC (FRMM) — 8-K Filings

All 8-K filings from Forum Markets INC. Browse 50 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (50)

FORUM MARKETS Joins AI Chip Infrastructure Initiative — Apr 8, 2026 Risk: medium
On April 8, 2026, FORUM MARKETS Inc. announced its participation in the AI Chip Infrastructure initiative. The company filed a current report (8-K) detailing th
FORUM MARKETS Inc. Amends Sales Agreement — Apr 8, 2026 Risk: low
On April 8, 2026, FORUM MARKETS Inc. entered into a Second Amended and Restated Sales Agreement. This agreement amends a previous sales agreement, with the spec
ETHZilla Corp Files 8-K: Material Agreement Termination — Dec 30, 2025 Risk: medium
On December 30, 2025, ETHZilla Corporation filed an 8-K to report the termination of a material definitive agreement and other events. The company, formerly kno
ETHZilla Corp Announces Executive & Board Changes — Dec 19, 2025 Risk: medium
On December 19, 2025, ETHZilla Corporation filed an 8-K report detailing changes in its executive team and board of directors. The filing includes information o
8-K Filing — Dec 16, 2025
8-K Filing — Dec 10, 2025
ETHZilla Corp Completes Acquisition, Changes Name — Dec 3, 2025 Risk: medium
On December 2, 2025, ETHZilla Corporation entered into a material definitive agreement related to the completion of an acquisition. The company, formerly known
ETHZilla Corp Reports Director/Officer Changes & Compensatory Arrangements — Dec 1, 2025 Risk: medium
On December 1, 2025, ETHZilla Corporation filed an 8-K report detailing changes in its board of directors and executive officers, as well as updates to compensa
8-K Filing — Nov 25, 2025
ETHZilla Corp. Files 8-K: Regulation FD & Financials — Oct 29, 2025 Risk: low
On October 29, 2025, ETHZilla Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. ETHZilla
ETHZilla Corp. Files 8-K with Financials — Oct 27, 2025 Risk: low
On October 27, 2025, ETHZilla Corp. filed an 8-K report. The filing indicates a change in its reporting status and includes financial statements and exhibits. T
ETHZilla Corp. Completes Acquisition, Enters Material Agreement — Oct 23, 2025 Risk: medium
On October 22, 2025, ETHZilla Corp. (formerly 180 Life Sciences Corp. and KBL Merger Corp. IV) entered into a material definitive agreement and completed an acq
ETHZilla Corp Files 8-K on Security Holder Rights & Bylaws — Oct 15, 2025 Risk: medium
ETHZilla Corporation filed an 8-K on October 15, 2025, reporting events as of October 14, 2025. The filing indicates material modifications to security holder r
ETHZilla Corp. Files 8-K with Key Corporate Updates — Oct 8, 2025 Risk: medium
ETHZilla Corp. filed an 8-K on October 8, 2025, reporting several key events. These include material modifications to security holder rights, changes in officer
ETHZilla Corp Files 8-K Report — Sep 30, 2025 Risk: medium
On September 30, 2025, ETHZilla Corporation filed an 8-K report. The filing indicates a change in the company's structure or operations, as it is listed under '
ETHZilla Corp. Files 8-K: Material Agreements & Equity Sales — Sep 22, 2025 Risk: medium
ETHZilla Corp. entered into a material definitive agreement on September 22, 2025, which also created a direct financial obligation. The company also disclosed
ETHZilla Corp. Files 8-K, Shifts Focus to Crypto Assets — Sep 15, 2025 Risk: medium
On September 15, 2025, ETHZilla Corp. filed an 8-K report. The filing indicates a change in its business focus, previously operating as 180 Life Sciences Corp.
ETHZilla Corp. Enters Material Definitive Agreement — Sep 8, 2025 Risk: medium
On September 5, 2025, ETHZilla Corp. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as 180 Li
ETHZilla Corp. Files 8-K on Material Agreements & Officer Changes — Sep 5, 2025 Risk: medium
ETHZilla Corp. (formerly 180 Life Sciences Corp.) filed an 8-K on September 5, 2025, reporting on several material events as of September 2, 2025. These include
ETHZilla Corp to Acquire 03 Life Sciences — Sep 2, 2025 Risk: medium
ETHZilla Corporation (formerly 180 Life Sciences Corp.) announced on August 28, 2025, that it has entered into a definitive agreement to acquire all outstanding
ETHZilla Corp. Enters Material Definitive Agreement — Aug 25, 2025 Risk: medium
On August 22, 2025, ETHZilla Corp. (formerly 180 Life Sciences Corp. and KBL Merger Corp. IV) entered into a material definitive agreement. The company, incorpo
180 Life Sciences Corp. Files 8-K: Material Agreement & Equity Sales — Aug 14, 2025 Risk: medium
On August 13, 2025, 180 Life Sciences Corp. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of equity s
180 Life Sciences Files 8-K on Equity Sales & Bylaw Changes — Aug 13, 2025 Risk: medium
180 Life Sciences Corp. filed an 8-K on August 13, 2025, reporting unregistered sales of equity securities and amendments to its articles of incorporation or by
180 Life Sciences Corp. Files 8-K Report — Aug 12, 2025 Risk: low
On August 12, 2025, 180 Life Sciences Corp. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and other events, including financial s
180 Life Sciences Corp. Files 8-K with Key Corporate Updates — Aug 11, 2025 Risk: medium
On August 7, 2025, 180 Life Sciences Corp. entered into a material definitive agreement, likely related to its common stock and warrants. The company also repor
180 Life Sciences Corp. Files 8-K: Agreements, Equity Sales, Officer Changes — Aug 5, 2025 Risk: medium
On July 31, 2025, 180 Life Sciences Corp. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and
8-K Filing — Jul 30, 2025
180 Life Sciences Corp. Files 8-K with Corporate Updates — Jul 24, 2025 Risk: medium
On July 24, 2025, 180 Life Sciences Corp. filed an 8-K report detailing several key events. These include material modifications to security holder rights, chan
180 Life Sciences Corp. Files 8-K on Executive and Director Changes — Jul 14, 2025 Risk: medium
On July 11, 2025, 180 Life Sciences Corp. filed an 8-K report detailing changes in its board of directors and executive officers. The filing also addresses comp
180 Life Sciences Corp. Files 8-K Report — Jul 1, 2025 Risk: low
On July 1, 2025, 180 Life Sciences Corp. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific mat
180 Life Sciences Files 8-K on Shareholder Nominations — Jun 25, 2025 Risk: low
On June 25, 2025, 180 Life Sciences Corp. filed an 8-K report detailing shareholder nominations for its board of directors and other events. The company, previo
180 Life Sciences Corp. Files 8-K on Equity Sales — Jun 20, 2025 Risk: medium
On June 17, 2025, 180 Life Sciences Corp. reported on the unregistered sale of equity securities and other events. The company, formerly known as KBL Merger Cor
180 Life Sciences Corp. Files 8-K with Agreement Termination, Director Changes — Jun 18, 2025 Risk: medium
On June 12, 2025, 180 Life Sciences Corp. reported on several key events including the termination of a material definitive agreement and changes in its board o
180 Life Sciences Corp. Files 8-K Report — May 1, 2025 Risk: low
On May 1, 2025, 180 Life Sciences Corp. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." The company,
180 Life Sciences Corp. Files 8-K for Material Agreement — Apr 30, 2025 Risk: medium
On April 28, 2025, 180 Life Sciences Corp. entered into a material definitive agreement. The company, formerly known as KBL Merger Corp. IV, is incorporated in
180 Life Sciences Corp. Files 8-K: Material Agreement & Equity Sales — Apr 9, 2025 Risk: medium
On April 6, 2025, 180 Life Sciences Corp. entered into a material definitive agreement. The company also reported unregistered sales of equity securities and fi
180 Life Sciences Corp. Files 8-K: Agreements & Equity Sales — Feb 25, 2025 Risk: medium
On February 21, 2025, 180 Life Sciences Corp. filed an 8-K report detailing a material definitive agreement, unregistered sales of equity securities, and financ
180 Life Sciences Corp. Files 8-K on Officer/Director Changes — Feb 21, 2025 Risk: medium
180 Life Sciences Corp. filed an 8-K on February 21, 2025, reporting on events as of February 15, 2025. The filing covers the departure of directors or officers
180 Life Sciences Corp. Files 8-K with Material Agreements & Officer Changes — Feb 7, 2025 Risk: medium
On February 4, 2025, 180 Life Sciences Corp. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, unre
180 Life Sciences Corp. Files 8-K with Board Changes and Shareholder Votes — Dec 31, 2024 Risk: medium
On December 27, 2024, 180 Life Sciences Corp. filed an 8-K report detailing several key events. These include the departure of directors, election of new direct
180 Life Sciences Corp. Files 8-K with Material Agreements — Dec 30, 2024 Risk: medium
On December 27, 2024, 180 Life Sciences Corp. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, unr
180 Life Sciences Corp. Reports Board and Compensation Changes — Dec 18, 2024 Risk: medium
180 Life Sciences Corp. announced on December 16, 2024, changes in its board of directors and executive compensation arrangements. The filing details the depart
180 Life Sciences Files 8-K: Other Events & Financials — Dec 12, 2024 Risk: low
On December 10, 2024, 180 Life Sciences Corp. filed an 8-K report detailing "Other Events" and "Financial Statements and Exhibits." The filing was made on Decem
180 Life Sciences Corp. Files 8-K on Director/Officer Changes — Dec 4, 2024 Risk: medium
180 Life Sciences Corp. filed an 8-K on December 4, 2024, reporting on events as of December 2, 2024. The filing covers the departure of directors, election of
180 Life Sciences Corp. Files 8-K — Oct 31, 2024 Risk: low
180 Life Sciences Corp. filed an 8-K on October 31, 2024, reporting on financial statements and exhibits. The company, formerly known as KBL Merger Corp. IV, is
180 Life Sciences Corp. Files 8-K: Board, Officer, and Financial Updates — Oct 29, 2024 Risk: low
On October 24, 2024, 180 Life Sciences Corp. filed an 8-K report detailing changes in its board of directors and officer compensation. The filing also includes
180 Life Sciences Corp. Reports Unregistered Equity Sale — Oct 21, 2024 Risk: medium
On October 17, 2024, 180 Life Sciences Corp. reported an unregistered sale of equity securities. The company, formerly known as KBL Merger Corp. IV, is incorpor
180 Life Sciences Files 8-K with Financials — Oct 16, 2024 Risk: low
On October 16, 2024, 180 Life Sciences Corp. filed an 8-K report. The filing indicates that the company is providing financial statements and exhibits. No other
180 Life Sciences Files 8-K — Oct 9, 2024 Risk: low
180 Life Sciences Corp. filed an 8-K on October 9, 2024, reporting an event that occurred on October 4, 2024. The filing is related to financial statements and
180 Life Sciences Corp. Completes Acquisition, Reports Equity Sales — Oct 3, 2024 Risk: medium
180 Life Sciences Corp. announced on September 29, 2024, the completion of its acquisition of the assets of a private company. The company also reported on unre

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX